登录
 机构网站
  1. 首页
  2. 情报产品
  3. 快讯详情

《自我检测HIV-1》

  • 来源专题：艾滋病防治
  • 编译者： 李越
  • 发布时间：2005-03-11
  • AIDS is a serious disease that can be fatal. You can determine if you are infected with the Human Immunodeficiency Virus-1 (HIV-1), the virus that causes AIDS, by taking a test for the presence of antibodies to the virus. A sample for testing can now be collected in your own home. There are a number of different HIV home collection test systems and kits that have appeared on the market, available through the Internet and through magazine or newspaper promotions. However, only one HIV-1 Home Collection Test System is currently approved by the United States Food and Drug Administration (FDA):Home Access Express HIV-1 Test System manufactured by Home Access Health Corporation. The other HIV-1 home test kits being advertised have not been approved by the FDA for use and marketing in the United States. These unapproved HIV home test kits claim to detect antibodies to HIV-1, the virus that causes AIDS, in blood or saliva, providing results in the home in fifteen minutes or less.
  • 原文来源：http://www.fda.gov/cber/infosheets/hiv-home.htm
23浏览量
原文链接
相关报告

  • 《HIV-1耐药的基因型检测》
    • 来源专题：艾滋病防治
    • 编译者：李越
    • 发布时间：2005-04-17
    • There are 16 approved human immunodeficiency virus type 1 (HIV-1) drugs belonging to three mechanistic classes: protease inhibitors, nucleoside and nucleotide reverse transcriptase (RT) inhibitors, and nonnucleoside RT inhibitors. HIV-1 resistance to these drugs is caused by mutations in the protease and RT enzymes, the molecular targets of these drugs. Drug resistance mutations arise most often in treated individuals, resulting from selective drug pressure in the presence of incompletely suppressed virus replication. HIV-1 isolates with drug resistance mutations, however, may also be transmitted to newly infected individuals. Three expert panels have recommended that HIV-1 protease and RT susceptibility testing should be used to help select HIV drug therapy. Although genotypic testing is more complex than typical antimicrobial susceptibility tests, there is a rich literature supporting the prognostic value of HIV-1 protease and RT mutations. This review describes the genetic mechanisms of HIV-1 drug resistance and summarizes published data linking individual RT and protease mutations to in vitro and in vivo resistance to the currently available HIV drugs.
    23浏览量
    原文链接

  • 《Alu-LTR PCR检测整合型HIV-1实验方法的优化》
    • 来源专题：艾滋病防治
    • 编译者：李越
    • 发布时间：2012-12-25
    • 对Alu-LTRPCR检测整合型HIV-1的实验方法进行优化。方法收集20例HIV-1感染患者及10例健康对照者的抗凝血标本,纯化CD4＋T细胞并提取DNA,根据整合型HIV-1DNA的特点设计引物,首轮PCR5′端引物来自于人类保守的Alu序列,3′端引物来自于HIV-1LTRU5区序列,扩增片段包含了整合位点上游的人类基因组DNA序列和整合的HIV-1LTR的序列。第二轮引物针对HIV-1LTRU3区的序列。在首轮PCR基础上,PCR产物稀释后进行第二轮PCR。结果经过优化的Alu-LTRPCR,20例HIV病人全部检测到整合的HIV-1。结论经优化后,Alu-LTRPCR检测整合型HIV-1的实验方法的灵敏度明显提高。
    67浏览量
    原文链接